CV Risk Lower with Metformin
SAN DIEGO—Older patients with type 2 diabetes have a significantly higher likelihood of experiencing a cardiovascular (CV) event within two years if they start treatment with a sulfonylurea drug than with metformin, researchers reported at the 71st Scientific Sessions of the American Diabetes Association.
